Skip to main content
SAMIL PHARMACEUTICAL CO.,LTD logo

SAMIL PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 000520 ISIN · KR7000520007 KO Manufacturing
Filings indexed 336 across all filing types
Latest filing 2021-04-16 Major Shareholding Noti…
Country KR South Korea
Listing KO 000520

About SAMIL PHARMACEUTICAL CO.,LTD

https://www.samil-pharm.com/main/EN

Samil Pharmaceutical Co., Ltd. is a company engaged in the research, development, and manufacturing of pharmaceutical products. The company specializes in ophthalmology and also produces a diverse portfolio of drugs for other therapeutic areas, including the central nervous system (CNS), hepatic conditions, and gastrointestinal disorders. Its product range encompasses prescription medicines as well as over-the-counter remedies for common ailments like fever and colds. In addition to developing its own products, Samil Pharmaceutical offers Contract Development and Manufacturing Organization (CDMO) services to global partners. The company emphasizes research and development and collaborates with other leading pharmaceutical firms.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (DART system) used when an entity acquires 5% or more of a company's shares. This specific document details KB Securities' shareholding in Samil Pharmaceutical. According to the provided definitions, this falls under 'Major Shareholding Notification' (MRQ).
2021-04-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on the Status of Large Shareholdings' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the shareholding status of KB Securities in Samil Pharmaceutical. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks changes in significant ownership levels.
2021-04-16 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Samil Pharmaceutical. It details changes in share ownership for specific individuals and entities, primarily due to a stock split. This type of filing is a standard regulatory disclosure regarding major shareholding changes and insider ownership status, which falls under the 'Major Shareholding Notification' category.
2021-04-12 Korean
[기재정정]주식분할결정
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Samil Pharmaceutical regarding a 'Stock Split Decision' (주식분할 결정). It details the change in the number of shares and the par value per share, which constitutes a capital change. According to the provided definitions, announcements regarding stock splits or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2021-04-09 Korean
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Share Issue/Capital Change Classification · 100% confidence The document is an official regulatory announcement regarding the adjustment of conversion prices for convertible bonds due to a stock split. This type of filing relates to changes in capital structure and financial instruments, which falls under the category of capital/financing updates.
2021-04-08 Korean
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Samil Pharmaceutical regarding the adjustment of the exchange price for convertible bonds due to a stock split. This falls under capital structure changes and financing adjustments. Since it specifically details the adjustment of conversion/exchange prices for financial instruments, it fits best under the 'Capital/Financing Update' category.
2021-04-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.